The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I pilot study of personalized neoantigen peptide-based vaccine in combination with pembrolizumab in advanced solid tumors (PNeoVCA).
 
Yanyan Lou
Consulting or Advisory Role - AstraZeneca; Janssen; Lilly; Turning Point Therapeutics
Research Funding - Blueprint Medicines (Inst); Daiichi-Sankyo (Inst); Genmab (Inst); Merck (Inst); Mirati Therapeutics (Inst); Roche/Genentech (Inst); Tolero Pharmaceuticals (Inst)
 
Saranya Chumsri
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Athenex; Athenex; bioTheranostics; bioTheranostics (Inst); Eisai; Immunomedics; Immunomedics; Immunomedics; Novartis; Novartis; Puma Biotechnology; Seagen; Syndax
Research Funding - Array BioPharma; Merck; Salix
 
Yan W. Asmann
No Relationships to Disclose
 
Qian Shi
Honoraria - Chugai Pharma
Consulting or Advisory Role - Hoosier Cancer Research Network; Kronos Bio; Mirati Therapeutics; Regeneron; Yiviva
Research Funding - BMS (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Jordan Reynolds
No Relationships to Disclose
 
Brian Necela
No Relationships to Disclose
 
Nadine Norton
No Relationships to Disclose
 
Michael Gustafson
No Relationships to Disclose
 
Winston Tan
Honoraria - Medscape; Onclive
 
Rami Manochakian
Consulting or Advisory Role - Alpha 2; AstraZeneca; Bristol-Myers Squibb; Cardinal Health; Daiichi Sankyo inc; Guardant Health; Janssen; Novocure; Oncohost; Takeda; Turning Point Therapeutics
 
Yujie Zhao
Employment - Mayo Clinic; Mayo Clinic
Honoraria - Coherus Biosciences; Lilly
Consulting or Advisory Role - Coherus Biosciences; Lilly
Research Funding - Alpine Immune Sciences (Inst); Incyte (Inst); Merck (Inst); Mirati Therapeutics (Inst); PDS Biotechnology; Pfizer (Inst); Zai Lab
 
Hani M. Babiker
Consulting or Advisory Role - Celgene; Endocyte; Idera; Myovant Sciences; Novocure
Speakers' Bureau - Guardant Health
 
Trevanne Rose Matthews Hew
No Relationships to Disclose
 
Keith L. Knutson
Leadership - AffyImmune Therapeutics; Kiromic
Stock and Other Ownership Interests - Kiromic
Research Funding - Marker Therapeutics
Patents, Royalties, Other Intellectual Property - Mayo Clinic holds several patents of technologies that I have developed.